Dean Mitchell

Track

Insider profile

Currently holds positions in ImmunoGen Inc, Precigen Inc and Theravance Biopharma Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 28% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Co-Chairman of the Board ImmunoGen Inc Jan. 1, 2017 -
Independent Director Precigen Inc March 1, 2009 -
Independent Director Theravance Biopharma Inc June 1, 2014 -
Independent Director ImmunoGen Inc Jan. 30, 2012 - Jan. 1, 2017
Independent Director Ista Pharmaceuticals LLC July 13, 2004 - June 6, 2012
Dean Mitchell's trades of Precigen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-25 2023-09-22
US Precigen Inc (PGEN)
B Purchase
47,738 -2.6%
192.32
US$176,649 		47,738 -2.6% 192.32 US$176,649
2023-03-27 2023-03-24
B Purchase
6,393 +13.8%
84.46
US$2,925,713 		6,393 +13.8% 84.46 US$2,925,713
2022-06-09 2022-06-08
B Purchase
91,791 -45.1%
35.69
US$4,284,049 		91,791 -45.1% 35.69 US$4,284,049
2020-08-06 2020-08-06
B Purchase
1,581
6.28
£9,933 		1,581 6.28 £9,933